Open AccessSecond Mutations in EGFR Provide Clues to Acquired Resistance to Iressa and Tarceva
Publication year - 2005
Publication title -
cancer biology and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.166
H-Index - 113
eISSN - 1555-8576
pISSN - 1538-4047
DOI - 10.4161/cbt.4.3.1635
Subject(s) - gefitinib , erlotinib , medicine , lung cancer , epidermal growth factor receptor , oncology , cancer , egfr inhibitors , targeted therapy , cancer research
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom